PhaseBio Pharmaceuticals, Inc. (PHAS): Price and Financial Metrics


PhaseBio Pharmaceuticals, Inc. (PHAS)

Today's Latest Price: $4.06 USD

0.06 (-1.46%)

Updated Jan 27 9:00am

Add PHAS to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 239 in Medical - Pharmaceuticals

See all "A" rated Strong Buy stocks

PHAS Stock Price Chart Interactive Chart >

Price chart for PHAS

PHAS Price/Volume Stats

Current price $4.06 52-week high $6.85
Prev. close $4.12 52-week low $2.60
Day low $4.06 Volume 222
Day high $4.06 Avg. volume 299,013
50-day MA $3.90 Dividend yield N/A
200-day MA $4.05 Market Cap 119.22M

PhaseBio Pharmaceuticals, Inc. (PHAS) Company Bio


PhaseBio Pharmaceuticals, Inc. engages in the development and commercialization of biotherapeutics for the treatment of orphan diseases. It focuses on cardiopulmonary disorders. The company was founded by Ashutosh Chilkoti and Clay Bernardin Thorp in January 2002 and is headquartered in Malvern, PA.


PHAS Latest News Stream


Event/Time News Detail
Loading, please wait...

PHAS Latest Social Stream


Loading social stream, please wait...

View Full PHAS Social Stream

PHAS Price Returns

1-mo 19.06%
3-mo 40.00%
6-mo 1.50%
1-year -22.81%
3-year N/A
5-year N/A
YTD 20.83%
2020 -45.01%
2019 97.73%
2018 N/A
2017 N/A
2016 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.8063 seconds.